Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9604 posts found.

cancer-cell

Independent research may change the immunotherapy game

August 17, 2017 Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical

Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …
News
novo_flag

Novo diabetes drug outperforms Lilly rival at Phase 3

August 17, 2017 Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …
News
microscope-275984_960_720

Cancer Research UK and NU agree three-year research Astex Pharma deal

August 17, 2017 Research and Development, Sales and Marketing Astex pharmaceuticals, Cancer Research UK, Newcastle University, biotech, drugs, pharma, pharmaceutical

Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …
News
shutterstock

New personalised molecular blood test could shake up cancer treatment

August 16, 2017 Research and Development Cancer, life sciences, medicine, pharma, pharmaceutical, standford university

A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer which …
News
old-peoples-home-524234_960_720

Massive increase in UK care home places needed by 2025, report finds

August 16, 2017 Research and Development UK, UK government, biotech, drugs, pharma, pharmaceutical, social care

A study emerging from Newcastle University has pointed towards a potential crisis in care home places by 2025, as a …
News
opdivo_1_1

BMS left red-faced as Opdivo+Yervoy fails to beat rival Pfizer drug in kidney cancer

August 16, 2017 Research and Development BMS, Kidney cancer, Yervoy, life sciences, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has been left somewhat red-faced after its combination of Opdivo (nivolumab) and Yervoy (ipilimumab) failed to show any …
News
baby-1151345_960_720

Less sleep in children linked to increased risk of diabetes

August 16, 2017 Research and Development biotech, diabetes, drugs, pharma, pharmaceutical, type 2, type-2

A study emerging from St George’s University of London found that children who slept an hour less than the recommended …
News
heart_patch

Mending broken hearts with an injectable patch

August 16, 2017 Research and Development biotech, cardiovascular, drugs, heart disease, pharma, pharmaceutical

A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …
News
doug_langa

Novo Nordisk reshuffles Executive Management team with two major additions

August 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment, life sciences, medicine, pharma, pharmaceutical

This month has seen two new additions to Novo Nordisk’s Executive Management team. First of the pair is Camila Sylvest, …
Appointment
regeneron

Regeneron abandons respiratory syncytial virus therapy after late-stage failure

August 15, 2017 Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus

Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …
News
choles

Battling misinformation on the world’s biggest killer

August 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cardiovascular disease, cholesterol, healthcare, heart disease, heart failure, medicine, pharma, pharmaceutical

Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of …
Feature

Takeda strikes partnership to develop single-drug cancer combo immunotherapies

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals

Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …
News
shutterstock_95714119

Over 1,000 currently active cancer trials spell trouble for patient recruitment

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, drugs, life sciences, medicine, pharma, pharmaceutical

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …
News
brain-1787622_640

Early-stage study gives hope for rare and fatal neurodegenerative condition

August 11, 2017 Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …
News
shutterstock_87495637

Ending the era of $100,000 cancer drugs

August 11, 2017 Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026